Most a short while ago, it's been identified that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in similar regions as classical opioid receptors, it binds into a big range of endogenous opioids. Contrary to most opioid receptors, this receptor acts like a scavenger and will not act